Published in Allergy on March 01, 2006
Effect of the pruritus on the quality of life: a preliminary study. Ann Dermatol (2012) 1.03
Therapy of pruritus. Expert Opin Pharmacother (2010) 0.93
Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use. Postepy Dermatol Alergol (2013) 0.79
Topical therapies for pruritus. Semin Cutan Med Surg (2011) 0.78
Pimecrolimus cream in the management of patients with atopic eczema. Clin Cosmet Investig Dermatol (2009) 0.75
Pruritus in the elderly: clinical approaches to the improvement of quality of life. P T (2012) 0.75
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. J Clin Oncol (2004) 3.97
A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res (1999) 3.19
First sexual intercourse: age, coercion, and later regrets reported by a birth cohort. BMJ (1998) 3.14
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98
Complete amino acid sequence of the Mu heavy chain of a human IgM immunoglobulin. Science (1973) 2.97
Psychiatric disorders and risky sexual behaviour in young adulthood: cross sectional study in birth cohort. BMJ (2000) 2.87
Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J Biol Chem (1999) 2.85
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis (2011) 2.74
Oral contraceptives and fatal pulmonary embolism. Lancet (2000) 2.57
Folding patterns of porin and bacteriorhodopsin. EMBO J (1985) 2.34
A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med (1997) 2.29
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Sequence relationships of three human satellite DNAs. J Mol Biol (1986) 1.93
Waiting for elective surgery: effects on health-related quality of life. Int J Qual Health Care (1999) 1.90
Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro. Science (1986) 1.81
Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol (2012) 1.77
The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. Br J Dermatol (2001) 1.75
Mammographic screening: results from the 1996 National Breast Health Survey. Med J Aust (1997) 1.71
Cytokine modulation of keratinocyte cytokines. J Invest Dermatol (1990) 1.59
Importance of the male factor in cancer of the cervix. Lancet (1982) 1.58
Complete development of hepatic stages of Plasmodium falciparum in vitro. Science (1985) 1.58
Epidemiology of pelvic ring injuries. Injury (1996) 1.58
Sample-specific ratio effects in matching to sample. J Exp Anal Behav (1983) 1.58
Long-term administration of pancuronium and pipecuronium in the intensive care unit. Anesth Analg (1994) 1.56
Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol (2000) 1.55
Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients. Br J Dermatol (2005) 1.54
Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol (2004) 1.51
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study. Br J Dermatol (2013) 1.50
Early markers for protective mechanisms during rush venom immunotherapy. Allergy (2010) 1.50
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol (2012) 1.49
Occurrence of AIDS in New Zealand: the first seven years. MRC AIDS Epidemiology Group. N Z Med J (1991) 1.48
Hsp27 protects mitochondria of thermotolerant cells against apoptotic stimuli. Cell Stress Chaperones (2001) 1.47
Are we giving patients enough information on how to use topical treatments? Analysis of 767 prescriptions in psoriasis. Br J Dermatol (2011) 1.47
Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery. Exp Cell Res (1999) 1.47
Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1. Br J Dermatol (2014) 1.46
Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol (2001) 1.45
Pregnancies among New Zealand teenagers: trends, current status and international comparisons. N Z Med J (2000) 1.44
Oral contraceptives and breast cancer: a national study. Br Med J (Clin Res Ed) (1986) 1.44
Human mast cells produce IL-8. J Immunol (1993) 1.44
Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients. Allergy (2003) 1.44
Revisiting the enzymes stored in the laticifers of Carica papaya in the context of their possible participation in the plant defence mechanism. Cell Mol Life Sci (2001) 1.43
Patterns of disease and HIV testing at sexually transmitted disease clinics. N Z Med J (1997) 1.43
A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Br J Dermatol (2002) 1.42
High-frequency ultrasonography but not 930-nm optical coherence tomography reliably evaluates melanoma thickness in vivo: a prospective validation study. Br J Dermatol (2014) 1.42
Three variable-gene pools common to IgM, IgG and IgA immunoglobulins. Nature (1970) 1.41
EMLA cream as a topical anesthetic for the repeated mechanical debridement of venous leg ulcers: a double-blind, placebo-controlled study. J Am Acad Dermatol (1999) 1.41
Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial. Br J Dermatol (2012) 1.41
Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia. Leukemia (2010) 1.41
Leprosy type 1 reaction as the first manifestation of borderline lepromatous leprosy in a young native German. Br J Dermatol (1997) 1.39
[Atopic dermatitis. Version (17 July 2002 - modified final version)]. J Dtsch Dermatol Ges (2003) 1.39
Oral contraceptives and venous thromboembolism continued. N Z Med J (2000) 1.39
[Benign desmoplastic fibroblastoma of the lower leg. A rare case]. Unfallchirurg (2004) 1.39
Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy (2007) 1.39
Factors associated with sun protection compliance: results from a nationwide cross-sectional evaluation of 2215 patients from a dermatological consultation. Br J Dermatol (2014) 1.38
Incidence of cancer among Pacific Island people in New Zealand. N Z Med J (1993) 1.38
The extent of cervical screening in New Zealand women. N Z Med J (1991) 1.38
New treatment modalities for granuloma faciale. Br J Dermatol (2003) 1.31
Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol (1996) 1.31
Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites. Bull World Health Organ (1990) 1.30
Effects of maternal nutrition on the human fetus. Pediatrics (1973) 1.30
International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol (2003) 1.29
Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 1.26
Anti-mosquito midgut antibodies block development of Plasmodium falciparum and Plasmodium vivax in multiple species of Anopheles mosquitoes and reduce vector fecundity and survivorship. Proc Natl Acad Sci U S A (2001) 1.25
The small heat shock proteins family: the long forgotten chaperones. Int J Biochem Cell Biol (2012) 1.23
CONSORT adoption and quality of reporting of randomized controlled trials: a systematic analysis in two dermatology journals. Br J Dermatol (2009) 1.23
Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol (2013) 1.22
Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis. Clin Exp Dermatol (2006) 1.22
Late presentation of HIV infection among adults in New Zealand: 2005-2010. HIV Med (2011) 1.21
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy (2008) 1.20
Unlinked anonymous monitoring of HIV prevalence at sexually transmitted disease clinics. N Z Med J (1993) 1.19
Management of dermatofibrosarcoma protuberans with fibrosarcomatous transformation: an evidence-based review of the literature. J Eur Acad Dermatol Venereol (2011) 1.18
Breast cancer screening adherence: does church attendance matter? Health Educ Behav (1998) 1.18
The lifetime occurrence of sexually transmitted diseases among a cohort aged 21. N Z Med J (1996) 1.17
Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme. Br J Dermatol (2004) 1.16
Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. Proc Natl Acad Sci U S A (1990) 1.15
Psoriasis: rationale for targeting interleukin-17. Br J Dermatol (2012) 1.14
Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J Virol (1997) 1.14
Adoptive transfer of murine host protection to salmonellosis with T-cell growth factor-dependent, Salmonella-specific T-cell lines. Infect Immun (1985) 1.14
Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy (2008) 1.14
Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol (2010) 1.13
What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. J Eur Acad Dermatol Venereol (2010) 1.13
Olmsted syndrome--congenital palmoplantar and periorificial keratoderma. J Am Acad Dermatol (1984) 1.12
The high-affinity IgE receptor (FcepsilonRI) blocks apoptosis in normal human monocytes. J Clin Invest (2000) 1.10
What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol (2010) 1.10
Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA. Br J Dermatol (2005) 1.10
Progestogen-only oral contraceptives and risk of breast cancer in New Zealand. Cancer Causes Control (1996) 1.09
Pityriasis lichenoides of childhood with atypical CD30-positive cells and clonal T-cell receptor gene rearrangements. J Am Acad Dermatol (1996) 1.09
Structure and role of the five glycopeptides of human IgM immunoglobulins. Nat New Biol (1971) 1.08
Cyclin A is a mediator of p120E4F-dependent cell cycle arrest in G1. Mol Cell Biol (2001) 1.07
CD1 expression is not affected by human peptide transporter deficiency. Hum Immunol (1994) 1.07
Postprandial gallbladder motor function: refilling and turnover of bile in health and in cholelithiasis. Gastroenterology (1995) 1.06
The cardiac transplant recipient with disseminated intravascular coagulation--an unusual kidney donor. Transplantation (1993) 1.06
Viruses, specula, and cervical cancer. Lancet (1986) 1.06
Differential regulation of HSP27 oligomerization in tumor cells grown in vitro and in vivo. Oncogene (2000) 1.05
4beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo - effects of itraconazole in man. Int J Clin Pharmacol Ther (2009) 1.05